- Home
- Publications
- Publication Search
- Publication Details
Title
Risks and safety of biologics: A practical guide for allergists
Authors
Keywords
-
Journal
World Allergy Organization Journal
Volume 16, Issue 1, Pages 100737
Publisher
Elsevier BV
Online
2023-01-17
DOI
10.1016/j.waojou.2022.100737
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Pharmaceutical Industry in 2021. An Analysis of FDA Drug Approvals from the Perspective of Molecules
- (2022) Beatriz G. de la Torre et al. MOLECULES
- Non-infective cystitis secondary to benralizumab immunotherapy
- (2022) Toby Murray et al. BMJ Case Reports
- How to Assess Effectiveness of Biologics for Asthma and What Steps to Take When There Is Not Benefit
- (2021) Amber N. Pepper et al. Journal of Allergy and Clinical Immunology-In Practice
- Anti-IL-4Ralpha monoclonal antibody dupilumab mimics ulcerative colitis: a case report
- (2021) Yosuke Shimodaira et al. BMC GASTROENTEROLOGY
- Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma
- (2021) Andrew Menzies-Gow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dupilumab-induced psoriasis and alopecia areata: Case report and review of the literature
- (2021) J. Beaziz et al. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
- Cytokine-release hypersensitivity reaction after the first dose of benralizumab for severe eosinophilic asthma
- (2021) Dan Morgenstern-Kaplan et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial
- (2021) Sarah Diver et al. Lancet Respiratory Medicine
- Anaphylactic risk related to omalizumab, benralizumab, reslizumab, mepolizumab, and dupilumab
- (2021) Lisha Li et al. Clinical and Translational Allergy
- Omalizumab-associated eosinophilic granulomatosis with polyangiitis: cause or coincidence?
- (2021) Luke Nessan Carson et al. BMJ Case Reports
- A rare case of vernal keratoconjunctivitis in a patient with atopic dermatitis treated with tralokinumab
- (2021) B. Lai et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study
- (2021) Michael E Wechsler et al. Lancet Respiratory Medicine
- Acute onset of psoriasis in a patient with atopic dermatitis treated with dupilumab
- (2020) S. Ferrucci et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial
- (2020) J.I. Silverberg et al. BRITISH JOURNAL OF DERMATOLOGY
- Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)
- (2020) A. Wollenberg et al. BRITISH JOURNAL OF DERMATOLOGY
- Successful pregnancy in the setting of eosinophil depletion by benralizumab
- (2020) Scott Manetz et al. Journal of Allergy and Clinical Immunology-In Practice
- Disseminated herpes zoster following treatment with benralizumab
- (2019) Ajay Kumar Mishra et al. Clinical Respiratory Journal
- Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort
- (2019) Sarah Faiz et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: A pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and SOLO 2)
- (2019) Diamant Thaçi et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- The development of inflammatory arthritis and enthesitis in patients on dupilumab: a case series
- (2019) Z. N. Willsmore et al. BRITISH JOURNAL OF DERMATOLOGY
- Pregnancy Outcomes in the Omalizumab Pregnancy Registry and a Disease-matched Comparator Cohort
- (2019) Jennifer A. Namazy et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Rosacea Associated with Dupilumab Therapy
- (2019) Haley D. Heibel et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Case of alopecia areata during dupilumab treatment for atopic dermatitis
- (2019) Naoko Kanda et al. JOURNAL OF DERMATOLOGY
- Acute arthritis and arthralgia as an adverse drug reaction to dupilumab: a case report
- (2019) L.E.M de Wijs et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Dupilumab shows long-term safety and efficacy in moderate-to-severe atopic dermatitis patients enrolled in a phase 3 open-label extension study
- (2019) Mette Deleuran et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Laboratory safety of dupilumab in moderate‐to‐severe atopic dermatitis: results from three phase III trials ( LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS )
- (2019) A. Wollenberg et al. BRITISH JOURNAL OF DERMATOLOGY
- Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: the COSMEX Study
- (2019) Sandhya Khurana et al. CLINICAL THERAPEUTICS
- Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials
- (2019) Claus Bachert et al. LANCET
- Safety of Reslizumab in Uncontrolled Asthma with Eosinophilia: A Pooled Analysis from 6 Trials
- (2019) J. Christian Virchow et al. Journal of Allergy and Clinical Immunology-In Practice
- Occurrence of psoriasiform eruption during dupilumab therapy for adult atopic dermatitis: A case series
- (2019) Maddalena Napolitano et al. Dermatologic Therapy
- A Unique Case of Non-Cardiac Chest Pain Caused by Mepolizumab: Case Report and Review of the Literature
- (2019) Parker M Korbitz et al. Journal of Neurogastroenterology and Motility
- A Case of Serum Sickness-Like Reaction in an Adult Treated with Omalizumab
- (2019) Samuel L Weiss et al. MILITARY MEDICINE
- Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis
- (2019) Margitta Worm et al. JAMA Dermatology
- Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma
- (2018) William W. Busse et al. ADVANCES IN THERAPY
- Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma
- (2018) Klaus F. Rabe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
- (2018) Mario Castro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum sickness-like reaction in a pediatric patient using omalizumab for chronic spontaneous urticaria
- (2018) Amy Eapen et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma
- (2018) Sumita Khatri et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial
- (2018) William W Busse et al. Lancet Respiratory Medicine
- Anaphylaxis associated with omalizumab administration: Risk factors and patient characteristics
- (2017) Phillip L. Lieberman et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
- (2017) Andrew Blauvelt et al. LANCET
- Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma
- (2017) Parameswaran Nair et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of mepolizumab add-on therapy on health-related quality of life and markers of asthma control in severe eosinophilic asthma (MUSCA): a randomised, double-blind, placebo-controlled, parallel-group, multicentre, phase 3b trial
- (2017) Geoffrey L Chupp et al. Lancet Respiratory Medicine
- Long-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study
- (2016) Njira Lugogo et al. CLINICAL THERAPEUTICS
- Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
- (2016) Eugene R Bleecker et al. LANCET
- Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
- (2016) J Mark FitzGerald et al. LANCET
- Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
- (2016) Eric L. Simpson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of eosinophilic granulomatosis with poliangiitis (Churg-Strauss syndrome) and brain tumor in a patient after more than 7 years of omalizumab use: A case report
- (2015) S Borekci et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- The Xolair Pregnancy Registry (EXPECT): The safety of omalizumab use during pregnancy
- (2015) Jennifer Namazy et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab
- (2014) Aidan Long et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
- (2014) Elisabeth H. Bel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
- (2014) Hector G. Ortega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Omalizumab and the risk of malignancy: Results from a pooled analysis
- (2012) William Busse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
- (2012) Ian D Pavord et al. LANCET
- American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma & Immunology Omalizumab-Associated Anaphylaxis Joint Task Force follow-up report
- (2011) Linda Cox et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Development of Churg-Strauss syndrome with controlled asthma during omalizumab treatment
- (2008) Anne-Marie Ruppert et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Churg–Strauss syndrome associated with omalizumab
- (2007) Xavier Puéchal et al. European Journal of Internal Medicine
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started